• Chlorpromazine HCl in Host-Pathogen Cell Entry: Mechanistic

  2026-07-24

  Explore how Chlorpromazine HCl, a potent dopamine receptor antagonist, enables advanced investigation of cellular entry mechanisms in host-pathogen models. This article uniquely bridges neuropharmacology and infection biology, offering protocol guidance and novel insights for psychotic disorder and endocytosis research.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-07-24

  The DiscoveryProbe Protease Inhibitor Library delivers unmatched diversity and automation-ready convenience for high throughput screening of protease inhibition in cancer, apoptosis, and infectious disease research. This article offers granular workflow guidance, highlights strategic troubleshooting, and translates cutting-edge findings—like the PSMD14–CARM1 axis—into actionable assay decisions.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Research

  2026-07-23

  Chlorpromazine HCl is a validated dopamine receptor antagonist widely used in neuropharmacology and host-directed antibacterial research. Its mechanism involves potent, competitive inhibition of central dopamine receptors and modulation of neuroimmune pathways. APExBIO’s reagent (SKU B1480) remains a gold-standard tool for dissecting synaptic, endocytic, and macrophage functions.

• Pepstatin A (SKU A2571): Reliable Aspartic Protease Inhibiti

  2026-07-23

  This scenario-driven article addresses persistent challenges in cell viability and cytotoxicity workflows, demonstrating how Pepstatin A (SKU A2571) delivers reproducible inhibition of aspartic proteases in diverse research contexts. Drawing on peer-reviewed studies and product-specific parameters, it highlights best practices for experimental design, data interpretation, and vendor selection, positioning Pepstatin A as a robust solution for biomedical research.

• Tolazoline: Strategic Leverage of α2-Adrenergic Antagonism i

  2026-07-22

  This article delivers thought leadership for translational researchers by dissecting Tolazoline’s mechanistic profile as an α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker. Drawing on recent literature and highlighting strategic experimental guidance, we connect Tolazoline’s utility to advances in airway, islet, and neuroendocrine research. The piece uniquely bridges foundational pharmacology with translational priorities, integrating evidence-backed recommendations and situating Tolazoline’s role within the evolving competitive landscape.

• Stiripentol: LDH Inhibitor for Epilepsy and Metabolic Resear

  2026-07-22

  Stiripentol is a chemically distinct LDH inhibitor effective in modulating the astrocyte-neuron lactate shuttle and is widely utilized in Dravet syndrome and epilepsy research. Its mechanism involves noncompetitive inhibition of LDH1 and LDH5, altering lactate-pyruvate flux and cellular metabolism. Reliable, high-purity Stiripentol from APExBIO supports reproducible metabolic and neurological research.

• Tubastatin A: Precision HDAC6 Inhibition for Cardiac and Neu

  2026-07-21

  Explore the multifaceted research applications of Tubastatin A, a potent HDAC6 inhibitor, in cardiac and neurological protection. This article unveils mechanistic insights and practical guidance for assay design, setting it apart from existing content.

• Hexamethonium Bromide: Expanding the Frontiers of Autonomic

  2026-07-21

  Explore how Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic AChR, enables advanced research into sex-specific autonomic regulation. This article uniquely synthesizes mechanistic insights and assay design strategies for translational neuroscience.

• AZD1480: JAK2 Inhibitor Workflows for Tumor STAT3 Pathway An

  2026-07-20

  AZD1480 from APExBIO delivers precision for dissecting JAK2/STAT3 signaling in cancer models, enabling both standalone and combination strategies. This guide translates emerging evidence into actionable protocols, troubleshooting, and novel application insights for tumor biology research.

• Angiotensin 1/2 (2-7) Peptide: Bridging Cardiovascular and V

  2026-07-20

  Explore the unique dual role of the Angiotensin 1/2 (2-7) peptide in blood pressure regulation and SARS-CoV-2 spike protein binding. This article provides advanced insight into its molecular mechanisms and translational research value.

• TBST’s Translational Power: Precision Blocking in uPAR–uPA S

  2026-07-19

  Explore how TBST (Tris-Buffered Saline and Tween 20) transforms immunoassay workflows for translational cancer research, with mechanistic insights from uPAR–uPA interaction studies and actionable guidance to optimize assay reproducibility and clinical relevance.

• Verapamil ((±)-Verapamil): Applied Protocols in Hypoxia Rese

  2026-07-18

  Verapamil ((±)-Verapamil) extends well beyond cardiovascular models, uniquely enabling dissection of ROS/TXNIP/NLRP3-driven inflammation in hypoxia-exposed cells. From optimizing protocols to troubleshooting P-glycoprotein interactions, this article delivers actionable insights for modern research teams.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor Mechanism

  2026-07-17

  Sitagliptin phosphate monohydrate is a potent, selective DPP-4 inhibitor central to type II diabetes treatment research. It increases levels of incretin hormones by blocking DPP-4 and has demonstrated efficacy in metabolic and vascular models. APExBIO supplies validated, high-purity Sitagliptin phosphate monohydrate for research applications.

• Pathogen-Driven Identification of Macrophage Bacterial Killi

  2026-07-17

  Russell et al. introduce a pathogen-centric approach to discover host factors vital for macrophage-mediated killing of gram-positive bacteria. By leveraging adaptive variation in hypervirulent Streptococcus pneumoniae, the study reveals NAMPT, ACOD1/itaconate, and P2RX7 as actionable targets for host-directed therapies.

• Nav1.5 Ser571 Phosphorylation Drives Age-Related Cardiac Dys

  2026-07-16

  This study reveals that phosphorylation of the cardiac sodium channel Nav1.5 at Ser571 increases the late sodium current, leading to delayed ventricular repolarization and diastolic dysfunction in aging hearts. These mechanistic insights clarify the molecular basis behind age-associated cardiac electrical and mechanical deficits and highlight new directions for arrhythmia prevention research.

16297 records 1/1087 page Next 12345 下5页 Last page